A. A. Krivulyak

A. A. Krivulyak

Auto-generated profile, based on publicly available information

A. A. Krivulyak

Sechenov University

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 May 2026 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
AOA. R. Oskolkova
A. R. Oskolkova
AKA. A. Krivulyak
A. A. Krivulyak
AKA. R. Komelkova
A. R. Komelkova
VBVictoria Bitsadze
Victoria Bitsadze
JKJamilya Khizroeva
Jamilya Khizroeva
AMAlexander Makatsariya
Alexander Makatsariya
Preeclampsia (PE) is not only an acute obstetric complication but also a significant factor in long-term cardiovascular risk. This article analyzes the pathogenetic mechanisms linking recurrent severe PE with the development of chronic arterial hypertension, coronary heart disease, stroke, and heart failure in the long-term. Particular attention is paid to the two-stage PE model, as well as the key role for immune-inflammatory responses, oxidative stress, and hemostatic disorders. Recurrent PE is shown to cause cumulative damage to the vascular bed, transforming acute inflammation into chronic cardiovascular pathology. Neutrophil extracellular traps collectively resulting in innate immune activation, hypercoagulability, and endothelial damage, play a central role in the pathogenesis. Current approaches to preventing recurrent PE such as aspirin, calcium supplements, and low-molecular-weight heparins are discussed.